Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Impact of cyp3a5 polymorphisms on the treatment of chinese renal transplant recipients switching from cyclosporine to tacrolimus

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: WANG, Zhuo (Shanghai Changhai Hospital, SMMU, Department of Pharmacy, Shanghai, China)
  • Co-author(s): Wang, Xue Bin (Shanghai Changhai Hospital, SMMU, Shanghai, China)
    Xiao, Cheng Wu (Shanghai Changhai Hospital, SMMU, Shanghai, China)
    Yang, Qing (Shanghai Changhai Hospital, SMMU, Shanghai, China)
    Gao, Shen (Shanghai Changhai Hospital, SMMU, Shanghai, China)
    Wang, Lin Hui (Shanghai Changhai Hospital, SMMU, Shanghai, China)
  • Abstract:

    Background: Cyclosporine (CsA) and tacrolimus (FK506) are two of the most important immunosuppressive agents used in kidney transplantation. However, in some cases, CsA-based immunosuppressive regimen has to be switched to FK506-besed regimen. It is difficult to adjust the initial dose of FK506 after the regimen switching.
    Aims: This study was..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses